EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Toll-like receptors in cardiac hypertrophy

Yanan Zhang, Jimin Wu, Erdan Dong, Zhanli Wang, Han Xiao

Frontiers in Cardiovascular Medicine · 11.04.2023 · 10

DOI: 10.3389/fcvm.2023.1143583 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 11.04.2023. Verfasst von Yanan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Inner Mongolia Key Laboratory of Disease-Related Biomarkers, The Second Affiliated Hospital, Baotou Medical College, Baotou, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toll-like receptors (TLRs) are a family of pattern recognition receptors (PRRs) that can identify pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). TLRs play an important role in the innate immune response, leading to acute and chronic inflammation. Cardiac hypertrophy, an important cardiac remodeling phenotype during cardiovascular disease, contributes to the development of heart failure. In previous decades, many studies have reported that TLR-mediated inflammation was involved in the induction of myocardium hypertrophic remodeling, suggesting that targeting TLR signaling might be an effective strategy against pathological cardiac hypertrophy. Thus, it is necessary to study the mechanisms underlying TLR functions in cardiac hypertrophy. In this review, we summarized key findings of TLR signaling in cardiac hypertrophy.

Schlagwörter

Stichwörter der Autor:innen

cardiac hypertrophyinflammationinnate immunesignaling pathwaytoll-like receptor

Autor:innen und Institutionen

  • Inner Mongolia Key Laboratory of Disease-Related Biomarkers, The Second Affiliated Hospital, Baotou Medical College, Baotou, China.
  • Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.
  • NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University Third Hospital, Beijing, China.
  • Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, China.
  • Beijing Key Laboratory of Cardiovascular Receptors Research, Peking University Third Hospital, Beijing, China.
  • Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.

Zitieren

APA

Zhang, Y., Wu, J., Dong, E., Wang, Z., & Xiao, H. (2023). Toll-like receptors in cardiac hypertrophy. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1143583

Vancouver

Zhang Y, Wu J, Dong E, Wang Z, Xiao H. Toll-like receptors in cardiac hypertrophy. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1143583

BibTeX
@article{Zhang2023,
  author = {Zhang, Yanan and Wu, Jimin and Dong, Erdan and Wang, Zhanli and Xiao, Han},
  title = {Toll-like receptors in cardiac hypertrophy},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2023},
  volume = {10},
  doi = {10.3389/fcvm.2023.1143583}
}
Kostenlos starten →